A detailed history of Howland Capital Management LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Howland Capital Management LLC holds 8,814 shares of AZN stock, worth $592,124. This represents 0.03% of its overall portfolio holdings.

Number of Shares
8,814
Previous 9,590 8.09%
Holding current value
$592,124
Previous $747,000 8.17%
% of portfolio
0.03%
Previous 0.04%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$76.67 - $87.62 $59,495 - $67,993
-776 Reduced 8.09%
8,814 $686,000
Q2 2024

Aug 12, 2024

SELL
$66.81 - $80.83 $112,508 - $136,117
-1,684 Reduced 14.94%
9,590 $747,000
Q1 2024

May 03, 2024

SELL
$61.03 - $69.57 $2,075 - $2,365
-34 Reduced 0.3%
11,274 $763,000
Q4 2023

Jan 23, 2024

SELL
$61.89 - $69.28 $30,945 - $34,640
-500 Reduced 4.23%
11,308 $761,000
Q2 2023

Jul 28, 2023

SELL
$69.91 - $75.81 $133,598 - $144,872
-1,911 Reduced 13.93%
11,808 $845,000
Q1 2023

May 05, 2023

SELL
$63.15 - $71.6 $53,488 - $60,645
-847 Reduced 5.81%
13,719 $952,000
Q3 2022

Oct 17, 2022

SELL
$53.02 - $135.75 $1,431 - $3,665
-27 Reduced 0.19%
14,566 $799,000
Q2 2022

Jul 22, 2022

SELL
$59.26 - $71.14 $59,260 - $71,140
-1,000 Reduced 6.41%
14,593 $964,000
Q1 2022

Apr 27, 2022

SELL
$55.72 - $67.12 $26,912 - $32,418
-483 Reduced 3.0%
15,593 $1.03 Million
Q4 2021

Jan 26, 2022

BUY
$54.02 - $63.83 $5,834 - $6,893
108 Added 0.68%
16,076 $936,000
Q3 2021

Oct 25, 2021

SELL
$55.56 - $60.79 $52,948 - $57,932
-953 Reduced 5.63%
15,968 $959,000
Q4 2020

Jan 26, 2021

SELL
$48.52 - $58.02 $44,201 - $52,856
-911 Reduced 5.11%
16,921 $846,000
Q3 2020

Oct 26, 2020

SELL
$53.07 - $61.1 $1,220 - $1,405
-23 Reduced 0.13%
17,832 $977,000
Q2 2020

Jul 15, 2020

SELL
$43.1 - $55.31 $50,771 - $65,155
-1,178 Reduced 6.19%
17,855 $944,000
Q1 2020

Apr 13, 2020

SELL
$37.79 - $51.33 $23,996 - $32,594
-635 Reduced 3.23%
19,033 $850,000
Q4 2019

Jan 23, 2020

SELL
$42.46 - $50.46 $67,511 - $80,231
-1,590 Reduced 7.48%
19,668 $981,000
Q3 2019

Oct 22, 2019

BUY
$40.12 - $45.47 $69,126 - $78,344
1,723 Added 8.82%
21,258 $947,000
Q4 2018

Jan 23, 2019

SELL
$36.86 - $41.49 $147,440 - $165,960
-4,000 Reduced 17.0%
19,535 $742,000
Q3 2018

Oct 25, 2018

BUY
$34.76 - $39.72 $122,876 - $140,410
3,535 Added 17.68%
23,535 $931,000
Q2 2018

Jul 23, 2018

SELL
$34.55 - $37.05 $69,100 - $74,100
-2,000 Reduced 9.09%
20,000 $702,000
Q3 2017

Oct 30, 2017

BUY
$28.96 - $34.0 $637,120 - $748,000
22,000
22,000 $745,000

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $208B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Howland Capital Management LLC Portfolio

Follow Howland Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Howland Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Howland Capital Management LLC with notifications on news.